CN104856696A - Intelligent blood glucose test instrument, method and system - Google Patents

Intelligent blood glucose test instrument, method and system Download PDF

Info

Publication number
CN104856696A
CN104856696A CN201510306660.7A CN201510306660A CN104856696A CN 104856696 A CN104856696 A CN 104856696A CN 201510306660 A CN201510306660 A CN 201510306660A CN 104856696 A CN104856696 A CN 104856696A
Authority
CN
China
Prior art keywords
blood glucose
user
information
glucose value
value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510306660.7A
Other languages
Chinese (zh)
Other versions
CN104856696B (en
Inventor
张晓晓
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Zhongkekangyi Biotechnology Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510306660.7A priority Critical patent/CN104856696B/en
Publication of CN104856696A publication Critical patent/CN104856696A/en
Application granted granted Critical
Publication of CN104856696B publication Critical patent/CN104856696B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14552—Details of sensors specially adapted therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Emergency Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

An intelligent blood glucose test instrument comprises a shell component, an OTC detection component, a distance adjusting component, a data processing component and a display component. One sidewall of the shell component is provided with a cylindrical detection cavity used for containing one arm of a test object, and the detection cavity is parallel to the bottom surface of the shell component. The OTC detection component penetrates through the shell component and stretches into the detection cavity, and the OTC detection component is in thread fit with the shell component and moves vertically. The distance adjusting component is arranged on the sidewall, where the detection cavity is formed, of the shell component in a penetrating mode and penetrates through the detection cavity. The display component is arranged on the sidewall, adjacent to the detection cavity, of the shell component, the data process component is arranged in the shell component, and the data processing component is electrically connected with the OTC detection component and the display component. The OTC component comprises an OTC probe located in the detection cavity. The distance adjusting component comprises a rod body and a baffle. The baffle is fixedly connected with the end, close to the detection cavity, of the rod body. The rod body is provided with measurement scales. The rod body is in thread fit with the shell component and moves horizontally.

Description

Intelligent blood sugar tester, method of testing and system
Technical field
The present invention relates to blood glucose value technical field of measurement and test, particularly a kind of Intelligent blood sugar tester, method of testing and system.
Background technology
Along with significantly the increasing of onset diabetes rate in recent years in the world, blood sugar monitoring has been more and more requisite clinical means, at present for product mainly Peripheral blood glucose (finger tip blood) single measurement of patient's self detecting blood sugar, but to type i diabetes or the type ii diabetes patient using insulin treatment, other single measurement individual does not often reach the requirement controlling blood glucose; Need one and continuous blood sugar monitor and method can be provided, make patient know oneself blood glucose condition at any time, take measures in time, can symptom management most effectively, prevent complication, obtain higher quality of life.
In prior art, the existing blood glucose monitoring system being much suitable for family and using, comprises the blood glucose meter of microtrauma puncture and noninvasive blood glucose meter.At present by optical coherence tomography (Optical CoherenceTomography, be called for short OCT) be biomedical imaging technology of new generation after ultra sonic imaging, X ray CT, MRI, be applicable to the test of blood glucose, it is integrated with low coherence interference technology, confocal microscope principle and superhet Detection Techniques, can realize the noinvasive imaging to measured object internal structure.
But measure by OCT technology the interference that blood glucose is easily subject to tested user's skin thickness, whether age of user, user's skin exist the factor such as cicatrix and test position.The particularly test position of user's skin, there is larger impact in the measured value for blood glucose.Therefore people wish to carry out successional measurement at the same place skin of user to the blood glucose value of user usually.
One Chinese patent literature (CN20331496U) discloses and judges whether the pop one's head in distance in the tested region of Relative Skin of OCT changes and be secured in same place skin and carry out successional measurement to the blood glucose value of user by OCT probe acquires view data through computer analysis.
Such scheme needs to judge by complicated calculations the position that OCT pops one's head in, need hardware configuration complicated, and because data acquisition exists error, the model calculated is arranged cannot the positional information of complete reaction reality, therefore the hardware, the software cost that not only need of such scheme is high, and degree of accuracy is not high yet.
Summary of the invention
In view of this, the invention provides a kind of structure is simple, positional information degree of accuracy is high Intelligent blood sugar tester, method of testing and system.
A kind of Intelligent blood sugar tester, it comprises following assembly: a housing unit, an OTC detection components, a roll adjustment assembly, a data handling component, a display module;
Described housing unit one sidewall offers one for holding the cylindrical test chamber of tested object arm, and test chamber is parallel with housing unit bottom surface; OTC detection components stretches in test chamber through housing unit, and OTC detection components and housing unit are moved up and down by threaded engagement; Roll adjustment assembly is located in housing unit relative to the sidewall offering test chamber and runs through test chamber; Display module is arranged on housing unit and offers on the adjacent sidewall of test chamber, and data handling component is arranged in housing unit, and data handling component is electrically connected with OTC detection components, display module respectively;
OTC detection components comprises an OTC probe, and OTC probe is positioned at test chamber; Roll adjustment assembly comprises a body of rod, a baffle plate; Baffle plate is fixedly connected with body of rod one end near test chamber; Measurement scales offered by the body of rod; The body of rod and housing unit are moved horizontally by threaded engagement;
Data handling component for receiving and processing the skin optical initial data that OTC detection components sends, and sends to display module to show by processing the blood sugar effects that obtains; Display module for receiving the input information of user, and for video data processing components send information.
In Intelligent blood sugar tester of the present invention, data handling component comprises data processing module and data transmit-receive module; Data processing module is used for processing skin optical initial data, and data transmit-receive module is used for carrying out data interaction with OTC detection components, display module, cloud server.
In Intelligent blood sugar tester of the present invention, it also comprises a temperature sensing component, a sealing ring, a breather;
Sealing ring is arranged ringwise, adopts elastomeric material to make, is arranged on the opening part of test chamber; Breather extend in test chamber; Temperature sensing component extend in test chamber, and is electrically connected with data handling component.
A kind of Intelligent blood sugar method of testing, it is realized by the Intelligent blood sugar tester as described in above-mentioned any one, comprises the steps:
S1. age of user, sex and upper-arm circumference, brachium information is obtained according to the input of user; The age of user obtained, gender information are mated with the blood glucose reference data of cloud server, generates multiple dependency area sampling positional information, sampling depth information and user's skin texture model, blood glucose value generating reference model according to matching result;
S2. generate according to the dependency area sampling positional information obtained, sampling depth information and upper-arm circumference information and control activation bit relative to the OCT head angle of user's arm, control the anglec of rotation of activation bit adjustment OCT probe relative to user's arm by OCT head angle;
S3. generate user's arm according to dependency area sampling positional information and brachium information go deep into the depth information of Intelligent blood sugar instrument surveyed area and be shown to user;
S4., after a default testing time puts, prompting user carries out blood sugar test; Extend into after in test chamber at the arm of user, after the horizontal displacement that user adjusts OCT probe falling head and keeper after the first Preset Time, generate the activation bit triggering OCT probe acquires function, according to activation bit, the skin optical initial data of this dependency area sampling position of control OCT probe acquires, and reading revises through user's skin texture model the skin optical data obtained to skin optical initial data;
S5. according to the blood glucose value of revised this dependency area sampling position of skin optical data application blood glucose value generating reference model generation;
S6. step S4, S5 is repeated successively according to the arm mobile message of user until the blood glucose value of all dependency area sampling positional informationes all gathers complete; Judge whether the blood glucose value of all dependency area sampling positional informationes all gathers complete in the second Preset Time, when the blood glucose value having dependency area sampling positional information does not gather, generate and show the prompting of the blood glucose value collection activity of the dependency area sampling positional information that user's Resurvey does not complete, and jump to step S4, repeated execution of steps S4 to S6 successively; When the blood glucose value of all dependency area sampling positional informationes gathers complete, jump to step S7;
S7. according to the meansigma methods of all blood glucose values of all blood glucose value information generating reference evaluation informations gathered, comparative information and once complete collection, store and show the meansigma methods of all blood glucose values of this reference evaluation information, comparative information and this complete collection.
In Intelligent blood sugar method of testing of the present invention, described step S4 comprises:
S41., after a default testing time puts, prompting user carries out blood sugar test;
S42. extend into after in test chamber at the arm of user, judge temperature in test chamber whether within default Range of measuring temp by temperature sensor, when the temperature in test chamber is within default Range of measuring temp, jump to step S43; When temperature in test chamber exceedes default Range of measuring temp, generate the temperature control instruction regulating test chamber, be adjusted within default Range of measuring temp to the temperature of test chamber;
S43. user adjust OCT pop one's head in falling head and keeper horizontal displacement after, judge whether the horizontal displacement of OCT probe height or keeper after the first Preset Time changes;
S44., when the horizontal displacement of OCT probe height or keeper changes after the first Preset Time, continue wait one first Preset Time and jump to step S45; When the horizontal displacement of OCT probe height and keeper does not all change after the first Preset Time, directly jump to step S45;
S45. the activation bit triggering OCT probe acquires function is generated, according to the skin optical initial data of this dependency area sampling position of activation bit control OCT probe acquires, and read user's skin texture model and correction is carried out to skin optical initial data obtain skin optical data.
In Intelligent blood sugar method of testing of the present invention, described step S7 comprises following sub-step:
S71. after storing the meansigma methods of this time with reference to all blood glucose values of evaluation information, comparative information and this complete collection, judge this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference whether be less than first and preset threshold value of warning;
S72. this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be more than or equal to first preset threshold value of warning time, generating reminding user this measurement result wrong and suggestion user may carry out the signal language of hospital's check;
S73. this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be less than first preset threshold value of warning time, judge further this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference whether be less than the second default threshold value of warning;
S74. this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be more than or equal to second preset threshold value of warning time, generate the signal language of reminding user input diet information, after acquisition user inputs diet information, send it to cloud server, after receiving the dietary recommendation scheme that cloud server sends, be together shown to user with the meansigma methods of all blood glucose values with reference to evaluation information, comparative information and this complete collection; This blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be less than second preset threshold value of warning time, display is with reference to the meansigma methods of all blood glucose values of evaluation information, comparative information and this complete collection.
In Intelligent blood sugar method of testing of the present invention, described user's skin texture model is as follows:
C 0 = 1 + f [ ( S 2 1 + ( λ - 1 ) k ) 1 + h ( x ) · n ] · m ; C in above-mentioned formula 0for blood glucose association factor, s is detection faces product value, and h is for detecting depth value, and λ is for detecting light wave long value, and k is interference factor, and n is skin refractive index, and m is skin modifying factor, and x is for detecting light energy value.
In Intelligent blood sugar method of testing of the present invention, blood glucose value generating reference model is as follows:
L = Σ i = 1 I ( C o - 1 ) 2 · β ; In above-mentioned formula, I is the number of test point, and i is current test point ranking value, and β is Error Correction Factors.
A kind of Intelligent blood sugar test macro, it is realized by the Intelligent blood sugar tester as described in above-mentioned any one, comprises as lower unit:
Index selection unit, for obtaining age of user, sex and upper-arm circumference, brachium information according to the input of user; The age of user obtained, gender information are mated with the blood glucose reference data of cloud server, generates multiple dependency area sampling positional information, sampling depth information and user's skin texture model, blood glucose value generating reference model according to matching result;
OCT regulon, controlling activation bit for generating according to the dependency area sampling positional information obtained, sampling depth information and upper-arm circumference information relative to the OCT head angle of user's arm, controlling the anglec of rotation of activation bit adjustment OCT probe relative to user's arm by OCT head angle;
First display unit, gos deep into the depth information of Intelligent blood sugar instrument surveyed area for generating user's arm according to dependency area sampling positional information and brachium information and is shown to user;
Raw data acquisition unit, for after a default testing time puts, prompting user carries out blood sugar test; Extend into after in test chamber at the arm of user, after the horizontal displacement that user adjusts OCT probe falling head and keeper after the first Preset Time, generate the activation bit triggering OCT probe acquires function, according to activation bit, the skin optical initial data of this dependency area sampling position of control OCT probe acquires, and reading revises through user's skin texture model the skin optical data obtained to skin optical initial data;
Blood glucose value generation unit, for the blood glucose value according to revised this dependency area sampling position of skin optical data application blood glucose value generating reference model generation;
Repetitive, for according to the function of the arm mobile message of user successively repeated priming raw data acquisition unit, blood glucose value generation unit until the blood glucose value of all dependency area sampling positional informationes all gathers complete; Judge whether the blood glucose value of all dependency area sampling positional informationes all gathers complete in the second Preset Time, when the blood glucose value having dependency area sampling positional information does not gather, generate and show the prompting of the blood glucose value collection activity of the dependency area sampling positional information that user's Resurvey does not complete, and start the function of raw data acquisition unit, repeated priming raw data acquisition unit, blood glucose value generation unit, repetitive successively; When the blood glucose value of all dependency area sampling positional informationes gathers complete, start the function of the second display unit;
Second display unit, for the meansigma methods of all blood glucose values according to all blood glucose value information generating reference evaluation informations gathered, comparative information and once complete collection, store and show the meansigma methods of all blood glucose values of this reference evaluation information, comparative information and this complete collection.
Advantageous Effects: Intelligent blood sugar tester of the present invention make use of the arm length of tested user, hand size is all metastable rule in significant period of time, move horizontally the distance of regulating fender by the body of rod and housing unit by threaded engagement, such user just can support on baffle plate after stretching palm, and whether the arm observing user by being opened in estimating on the body of rod being in suitable test position, also being moved up and down by threaded engagement by OTC detection components and housing unit and the skin of user and OTC being popped one's head in fit.Structure of the present invention is simple, do not need to judge by complicated calculations the position that OCT pops one's head in, therefore do not need hardware configuration complicated, and whether the arm observing user due to the Measurement scales completely by frame for movement is in suitable test position, can the positional information of complete reaction reality, therefore hardware, the software cost ground of the solution of the present invention, and degree of accuracy is high.
Accompanying drawing explanation
Fig. 1 is the axonometric chart of the Intelligent blood sugar tester that the embodiment of the present invention provides;
Fig. 2 is the profile of Intelligent blood sugar tester in Fig. 1;
Fig. 3 is the structured flowchart of the Intelligent blood sugar test macro that the embodiment of the present invention provides.
Detailed description of the invention
In embodiments of the present invention, as shown in Figure 1, 2, a kind of Intelligent blood sugar tester, it comprises following assembly: housing unit 1, OTC detection components 2, roll adjustment assembly 3, data handling component, a display module 4.
Described housing unit 1 one sidewall offers one for holding the cylindrical test chamber of tested object arm, and test chamber is parallel with housing unit 1 bottom surface; OTC detection components 2 stretches in test chamber through housing unit 1, and OTC detection components 2 and housing unit 1 are moved up and down by threaded engagement; Roll adjustment assembly 3 is located in housing unit 1 relative to the sidewall offering test chamber and runs through test chamber; Display module 4 is arranged on housing unit 1 and offers on the adjacent sidewall of test chamber, and data handling component (attached not shown) is arranged in housing unit 1, and data handling component is electrically connected with OTC detection components 2, display module 4 respectively.
Alternatively, described housing unit 1 can be cuboid-type.The axis of test chamber and plane-parallel.OTC detection components 2 is chosen as cylindrical, housing unit 1 is offered the through hole leading to test chamber, OTC detection components 2 and housing unit 1 are moved up and down by threaded engagement, external screw thread can be offered on the outer wall of OTC detection components 2, both helicitic textures along offering female thread, or are carried out threaded engagement by through hole week conversely.Alternatively, display module 4 can be the LCDs with touch screen.
OTC detection components 2 comprises a test rod, a drive motors (be arranged on test rod in), an OTC pop one's head in, and 21, OTC probe 21 is positioned at test chamber; Roll adjustment assembly 3 comprises the body of rod 31, baffle plate 33; Baffle plate 33 is fixedly connected with the body of rod 31 one end near test chamber; The body of rod 31 is offered Measurement scales 32; The body of rod 31 and housing unit 1 are moved horizontally by threaded engagement.OTC probe 21 can freely rotate in OTC detection components 2.Drive motors respectively OTC probe 21 is electrically connected with data handling component, and the driving instruction that can receive data handling component drives OTC probe 21 adjustment position.
Data handling component for receiving and processing the skin optical initial data that OTC detection components 2 sends, and sends to display module 4 to show by processing the blood sugar effects that obtains; Display module 4 for receiving the input information of user, and for video data processing components send information.
Alternatively, data handling component comprises data processing module and data transmit-receive module; Data processing module is used for processing skin optical initial data, and data transmit-receive module is used for carrying out data interaction with OTC detection components 2, display module 4, cloud server.
Alternatively, it also comprises a temperature sensing component, a sealing ring, a breather.Attached not shown above.
Sealing ring is arranged ringwise, adopts elastomeric material to make, is arranged on the opening part of test chamber; Breather extend in test chamber; Temperature sensing component extend in test chamber, and is electrically connected with data handling component.By arranging the sealing ring of annular, after the arm of user stretches into test chamber, the week of sealing ring is along fitting with arm.This gas passed into by breather can not be overflowed in test chamber, the temperature in test chamber can be made in long-time to keep constant, it also avoid the testing result of the variable effect blood glucose of temperature.Baffle plate 33 is selected as elastomeric material simultaneously, baffle plate 33 can be fitted tightly with housing unit 1.
The embodiment of the present invention also provides a kind of Intelligent blood sugar method of testing, and it is realized by the Intelligent blood sugar tester as described in above-mentioned any one, comprises the steps:
S1. age of user, sex and upper-arm circumference, brachium information is obtained according to the input of user; The age of user obtained, gender information are mated with the blood glucose reference data of cloud server, generates multiple dependency area sampling positional information, sampling depth information and user's skin texture model, blood glucose value generating reference model according to matching result.
Cloud server gathers the information such as various all ages and classes, upper-arm circumference, brachium by long-time, and distinguish the value that men and women gathers blood glucose, form a large amount of statistical datas, and classification analysis is carried out to these statistical datas, form multiple dependency area sampling positional information, sampling depth information and user's skin texture model, blood glucose value generating reference model with this.Dependency region adopts positional information to refer to the area of sampling location at user's arm, sampling.
S2. generate according to the dependency area sampling positional information obtained, sampling depth information and upper-arm circumference information and control activation bit relative to the OCT head angle of user's arm, control the anglec of rotation of activation bit adjustment OCT probe relative to user's arm by OCT head angle.
The OCT probe adjustment anglec of rotation is driven by the drive motors in OCT assembly.Go deep into the depth location of test chamber due to user and determine, adjustment is among a small circle carried out in the position that therefore this step is just popped one's head in OCT, makes the detection position of OTC probe 21 more accurate.
S3. generate user's arm according to dependency area sampling positional information and brachium information go deep into the depth information of Intelligent blood sugar instrument surveyed area and be shown to user.
By this step, user can be well understood to the sampling location that current OCT pops one's head in, in the event of error, adjustment can also be proceeded, OTC probe 21 is made to arrive suitable detection position, make to have stationarity to the detection position of blood glucose at every turn, thus make long blood sugar test have seriality, accuracy is high.
S4., after a default testing time puts, prompting user carries out blood sugar test; Extend into after in test chamber at the arm of user, after the horizontal displacement that user adjusts OCT probe falling head and keeper after the first Preset Time, generate the activation bit triggering OCT probe acquires function, according to activation bit, the skin optical initial data of this dependency area sampling position of control OCT probe acquires, and reading revises through user's skin texture model the skin optical data obtained to skin optical initial data.By arranging point of default testing time, user can be made to test blood glucose at a fixed time every day, on the one hand can carry out the diet of rule by reminding user, it also avoid the diet time variable effect testing result of user on the other hand, thus affect the contrast of historical data.By arranging the first Preset Time, can automatic sensing user whether adjust complete to the horizontal displacement of OCT probe falling head and keeper.
S5. according to the blood glucose value of revised this dependency area sampling position of skin optical data application blood glucose value generating reference model generation.
S6. step S4, S5 is repeated successively according to the arm mobile message of user until the blood glucose value of all dependency area sampling positional informationes all gathers complete; Judge whether the blood glucose value of all dependency area sampling positional informationes all gathers complete in the second Preset Time, when the blood glucose value having dependency area sampling positional information does not gather, generate and show the prompting of the blood glucose value collection activity of the dependency area sampling positional information that user's Resurvey does not complete, and jump to step S4, repeated execution of steps S4 to S6 successively; When the blood glucose value of all dependency area sampling positional informationes gathers complete, jump to step S7.By arranging the second Preset Time, once gathering completely of user can be avoided to cross over larger time range, and the blood glucose value of user there occurs larger change during this period, thus having affected the assessment result of blood glucose.And by generating and showing the prompting of the blood glucose value collection activity of the dependency area sampling positional information that user's Resurvey does not complete, and jump to step S4, repeated execution of steps S4 to S6 successively, avoids the undetected of user.
S7. according to the meansigma methods of all blood glucose values of all blood glucose value information generating reference evaluation informations gathered, comparative information and once complete collection, store and show the meansigma methods of all blood glucose values of this reference evaluation information, comparative information and this complete collection.
Comprise with reference to evaluation information: blood glucose value is normal, blood glucose value is higher, blood glucose value is on the low side, blood glucose value is too high, blood glucose value is too low, whether the blood glucose target that such user can observe oneself is intuitively normal, avoids the uninteresting property only having a blood glucose value.Comparative information comprises the contrast of the testing result of the same time with the previous day and the contrast with last testing result, and is shown by curve, and user can be allowed to observe the rule of oneself change of blood sugar intuitively.By gathering at multiple test point, and asking its draw value, substantially increasing the testing result accuracy of blood glucose value.
Alternatively, described step S4 comprises:
S41., after a default testing time puts, prompting user carries out blood sugar test.
S42. extend into after in test chamber at the arm of user, judge temperature in test chamber whether within default Range of measuring temp by temperature sensor, when the temperature in test chamber is within default Range of measuring temp, jump to step S43; When temperature in test chamber exceedes default Range of measuring temp, generate the temperature control instruction regulating test chamber, the temperature of test chamber is adjusted within default Range of measuring temp.By this step, avoid the impact of variations in temperature on blood glucose test results.
S43. user adjust OCT pop one's head in falling head and keeper horizontal displacement after, judge whether the horizontal displacement of OCT probe height or keeper after the first Preset Time changes.
S44., when the horizontal displacement of OCT probe height or keeper changes after the first Preset Time, continue wait one first Preset Time and jump to step S45; When the horizontal displacement of OCT probe height and keeper does not all change after the first Preset Time, directly jump to step S45.By this step, avoid long wait.First Preset Time can be arranged flexibly, meets the demand of different user.
S45. the activation bit triggering OCT probe acquires function is generated, according to activation bit, the skin optical initial data of this dependency area sampling position of control OCT probe acquires, and read user's skin texture model and correction is carried out to skin optical initial data obtain skin optical data.
Alternatively, described step S7 comprises following sub-step:
S71. after storing the meansigma methods of this time with reference to all blood glucose values of evaluation information, comparative information and this complete collection, judge this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference whether be less than first and preset threshold value of warning.First default early warning value is that the blood glucose of user there occurs larger fluctuation, has exceeded normal fluctuation range.
S72. this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be more than or equal to first preset threshold value of warning time, generating reminding user this measurement result wrong and suggestion user may carry out the signal language of hospital's check.By the setting of this step, avoid the danger of possible delay treatment, and the detection error message that mechanical disorder causes.Existing home-use blood glucose meter, when fluctuating larger, only shows a numerical value, and user does not know whether this result believing blood glucose meter, thus the treatment of likely delay treatment.
S73. this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be less than first preset threshold value of warning time, judge further this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference whether be less than the second default threshold value of warning;
S74. this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be more than or equal to second preset threshold value of warning time, generate the signal language of reminding user input diet information, after acquisition user inputs diet information, send it to cloud server, after receiving the dietary recommendation scheme that cloud server sends, be together shown to user with the meansigma methods of all blood glucose values with reference to evaluation information, comparative information and this complete collection; This blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be less than second preset threshold value of warning time, display is with reference to the meansigma methods of all blood glucose values of evaluation information, comparative information and this complete collection.Preset threshold value of warning by arranging second, can remind user, blood glucose there occurs larger fluctuation, should note it.By the large data of cloud server, pointed dietary recommendation scheme can be provided.
Alternatively, described user's skin texture model is as follows:
C 0 = 1 + f [ ( S 2 1 + ( λ - 1 ) k ) 1 + h ( x ) · n ] · m ; C in above-mentioned formula 0for blood glucose association factor, s is detection faces product value, and h is for detecting depth value, and λ is for detecting light wave long value, and k is interference factor, and n is skin refractive index, and m is skin modifying factor, and x is for detecting light energy value.Interference factor k and skin modifying factor m is obtained by a large amount of data statisticss.The span of interference factor k is 0.03-0.07; The span of skin modifying factor m is 12-23.8.
Alternatively, blood glucose value generating reference model is as follows:
L = Σ i = 1 I ( C o - 1 ) 2 · β ; In above-mentioned formula, I is the number of test point, and i is current test point ranking value, and β is Error Correction Factors.Current test point ranking value i is current test point and comes which position.The span of Error Correction Factors β is 1.64-4.56.Error Correction Factors can be revised the error of blood glucose value, is obtained by a large amount of data statisticss.
As described in Figure 3, the embodiment of the present invention separately provides a kind of Intelligent blood sugar test macro, and it is realized by the Intelligent blood sugar tester as described in above-mentioned any one, comprises as lower unit:
Index selection unit, for obtaining age of user, sex and upper-arm circumference, brachium information according to the input of user; The age of user obtained, gender information are mated with the blood glucose reference data of cloud server, generates multiple dependency area sampling positional information, sampling depth information and user's skin texture model, blood glucose value generating reference model according to matching result;
OCT regulon, controlling activation bit for generating according to the dependency area sampling positional information obtained, sampling depth information and upper-arm circumference information relative to the OCT head angle of user's arm, controlling the anglec of rotation of activation bit adjustment OCT probe relative to user's arm by OCT head angle;
First display unit, gos deep into the depth information of Intelligent blood sugar instrument surveyed area for generating user's arm according to dependency area sampling positional information and brachium information and is shown to user;
Raw data acquisition unit, for after a default testing time puts, prompting user carries out blood sugar test; Extend into after in test chamber at the arm of user, after the horizontal displacement that user adjusts OCT probe falling head and keeper after the first Preset Time, generate the activation bit triggering OCT probe acquires function, according to activation bit, the skin optical initial data of this dependency area sampling position of control OCT probe acquires, and reading revises through user's skin texture model the skin optical data obtained to skin optical initial data;
Blood glucose value generation unit, for the blood glucose value according to revised this dependency area sampling position of skin optical data application blood glucose value generating reference model generation;
Repetitive, for according to the function of the arm mobile message of user successively repeated priming raw data acquisition unit, blood glucose value generation unit until the blood glucose value of all dependency area sampling positional informationes all gathers complete; Judge whether the blood glucose value of all dependency area sampling positional informationes all gathers complete in the second Preset Time, when the blood glucose value having dependency area sampling positional information does not gather, generate and show the prompting of the blood glucose value collection activity of the dependency area sampling positional information that user's Resurvey does not complete, and start the function of raw data acquisition unit, repeated priming raw data acquisition unit, blood glucose value generation unit, repetitive successively; When the blood glucose value of all dependency area sampling positional informationes gathers complete, start the function of the second display unit;
Second display unit, for the meansigma methods of all blood glucose values according to all blood glucose value information generating reference evaluation informations gathered, comparative information and once complete collection, store and show the meansigma methods of all blood glucose values of this reference evaluation information, comparative information and this complete collection.
Intelligent blood sugar test macro and the Intelligent blood sugar method of testing of the embodiment of the present invention are one to one.
In this description, each embodiment adopts the mode of going forward one by one to describe, and what each embodiment stressed is the difference with other embodiments, between each embodiment identical similar portion mutually see.
Professional can also recognize further, in conjunction with unit and the algorithm steps of each example of embodiment disclosed herein description, can realize with electronic hardware, computer software or the combination of the two, in order to the interchangeability of hardware and software is clearly described, in the above description according to the functional composition and the step that generally describe each example.These functions perform with hardware or software mode actually, depend on application-specific and the design constraint of technical scheme.Professional and technical personnel can use distinct methods to realize described function to each specifically should being used for, but this realization should not exceed scope of the present invention.The software module that the method described in conjunction with embodiment disclosed herein or the step of algorithm can directly use hardware, processor to perform, or the combination of the two is implemented.Software module can be placed in any other forms of storage medium known in random access memory, internal memory, read only memory, electrically programmable ROM, electrically erasable ROM, depositor, hard disk, moveable magnetic disc, CD-ROM or technical field.
Be understandable that, for the person of ordinary skill of the art, other various corresponding change and distortion can be made by technical conceive according to the present invention, and all these change the protection domain that all should belong to the claims in the present invention with distortion.

Claims (9)

1. an Intelligent blood sugar tester, is characterized in that, it comprises following assembly: a housing unit, an OTC detection components, a roll adjustment assembly, a data handling component, a display module;
Described housing unit one sidewall offers one for holding the cylindrical test chamber of tested object arm, and test chamber is parallel with housing unit bottom surface; OTC detection components stretches in test chamber through housing unit, and OTC detection components and housing unit are moved up and down by threaded engagement; Roll adjustment assembly is located in housing unit relative to the sidewall offering test chamber and runs through test chamber; Display module is arranged on housing unit and offers on the adjacent sidewall of test chamber, and data handling component is arranged in housing unit, and data handling component is electrically connected with OTC detection components, display module respectively;
OTC detection components comprises an OTC probe, and OTC probe is positioned at test chamber; Roll adjustment assembly comprises a body of rod, a baffle plate; Baffle plate is fixedly connected with body of rod one end near test chamber; Measurement scales offered by the body of rod; The body of rod and housing unit are moved horizontally by threaded engagement;
Data handling component for receiving and processing the skin optical initial data that OTC detection components sends, and sends to display module to show by processing the blood sugar effects that obtains; Display module for receiving the input information of user, and for video data processing components send information.
2. Intelligent blood sugar tester as claimed in claim 1, it is characterized in that, data handling component comprises data processing module and data transmit-receive module; Data processing module is used for processing skin optical initial data, and data transmit-receive module is used for carrying out data interaction with OTC detection components, display module, cloud server.
3. Intelligent blood sugar tester as claimed in claim 2, it is characterized in that, it also comprises a temperature sensing component, a sealing ring, a breather;
Sealing ring is arranged ringwise, adopts elastomeric material to make, is arranged on the opening part of test chamber; Breather extend in test chamber; Temperature sensing component extend in test chamber, and is electrically connected with data handling component.
4. an Intelligent blood sugar method of testing, is characterized in that, it is realized by the Intelligent blood sugar tester as described in any one of claims 1 to 3, comprises the steps:
S1. age of user, sex and upper-arm circumference, brachium information is obtained according to the input of user; The age of user obtained, gender information are mated with the blood glucose reference data of cloud server, generates multiple dependency area sampling positional information, sampling depth information and user's skin texture model, blood glucose value generating reference model according to matching result;
S2. generate according to the dependency area sampling positional information obtained, sampling depth information and upper-arm circumference information and control activation bit relative to the OCT head angle of user's arm, control the anglec of rotation of activation bit adjustment OCT probe relative to user's arm by OCT head angle;
S3. generate user's arm according to dependency area sampling positional information and brachium information go deep into the depth information of Intelligent blood sugar instrument surveyed area and be shown to user;
S4., after a default testing time puts, prompting user carries out blood sugar test; Extend into after in test chamber at the arm of user, after the horizontal displacement that user adjusts OCT probe falling head and keeper after the first Preset Time, generate the activation bit triggering OCT probe acquires function, according to activation bit, the skin optical initial data of this dependency area sampling position of control OCT probe acquires, and reading revises through user's skin texture model the skin optical data obtained to skin optical initial data;
S5. according to the blood glucose value of revised this dependency area sampling position of skin optical data application blood glucose value generating reference model generation;
S6. step S4, S5 is repeated successively according to the arm mobile message of user until the blood glucose value of all dependency area sampling positional informationes all gathers complete; Judge whether the blood glucose value of all dependency area sampling positional informationes all gathers complete in the second Preset Time, when the blood glucose value having dependency area sampling positional information does not gather, generate and show the prompting of the blood glucose value collection activity of the dependency area sampling positional information that user's Resurvey does not complete, and jump to step S4, repeated execution of steps S4 to S6 successively; When the blood glucose value of all dependency area sampling positional informationes gathers complete, jump to step S7;
S7. according to the meansigma methods of all blood glucose values of all blood glucose value information generating reference evaluation informations gathered, comparative information and once complete collection, store and show the meansigma methods of all blood glucose values of this reference evaluation information, comparative information and this complete collection.
5. Intelligent blood sugar method of testing as claimed in claim 4, it is characterized in that, described step S4 comprises:
S41., after a default testing time puts, prompting user carries out blood sugar test;
S42. extend into after in test chamber at the arm of user, judge temperature in test chamber whether within default Range of measuring temp by temperature sensor, when the temperature in test chamber is within default Range of measuring temp, jump to step S43; When temperature in test chamber exceedes default Range of measuring temp, generate the temperature control instruction regulating test chamber, be adjusted within default Range of measuring temp to the temperature of test chamber;
S43. user adjust OCT pop one's head in falling head and keeper horizontal displacement after, judge whether the horizontal displacement of OCT probe height or keeper after the first Preset Time changes;
S44., when the horizontal displacement of OCT probe height or keeper changes after the first Preset Time, continue wait one first Preset Time and jump to step S45; When the horizontal displacement of OCT probe height and keeper does not all change after the first Preset Time, directly jump to step S45;
S45. the activation bit triggering OCT probe acquires function is generated, according to the skin optical initial data of this dependency area sampling position of activation bit control OCT probe acquires, and read user's skin texture model and correction is carried out to skin optical initial data obtain skin optical data.
6. Intelligent blood sugar method of testing as claimed in claim 4, it is characterized in that, described step S7 comprises following sub-step:
S71. after storing the meansigma methods of this time with reference to all blood glucose values of evaluation information, comparative information and this complete collection, judge this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference whether be less than first and preset threshold value of warning;
S72. this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be more than or equal to first preset threshold value of warning time, generating reminding user this measurement result wrong and suggestion user may carry out the signal language of hospital's check;
S73. this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be less than first preset threshold value of warning time, judge further this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference whether be less than the second default threshold value of warning;
S74. this blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be more than or equal to second preset threshold value of warning time, generate the signal language of reminding user input diet information, after acquisition user inputs diet information, send it to cloud server, after receiving the dietary recommendation scheme that cloud server sends, be together shown to user with the meansigma methods of all blood glucose values with reference to evaluation information, comparative information and this complete collection; This blood glucose value meansigma methods and last time blood glucose value meansigma methods between the absolute value of difference be less than second preset threshold value of warning time, display is with reference to the meansigma methods of all blood glucose values of evaluation information, comparative information and this complete collection.
7. Intelligent blood sugar method of testing as claimed in claim 4, it is characterized in that, described user's skin texture model is as follows:
C 0 = 1 + f [ ( S 2 1 + ( λ - 1 ) k ) 1 + h ( x ) · n ] · m ; C in above-mentioned formula 0for blood glucose association factor, s is detection faces product value, and h is for detecting depth value, and λ is for detecting light wave long value, and k is interference factor, and n is skin refractive index, and m is skin modifying factor, and x is for detecting light energy value.
8. Intelligent blood sugar method of testing as claimed in claim 7, it is characterized in that, blood glucose value generating reference model is as follows:
in above-mentioned formula, I is the number of test point, and i is current test point ranking value, and β is Error Correction Factors.
9. an Intelligent blood sugar test macro, is characterized in that, it is realized by the Intelligent blood sugar tester as described in any one of claims 1 to 3, comprises as lower unit:
Index selection unit, for obtaining age of user, sex and upper-arm circumference, brachium information according to the input of user; The age of user obtained, gender information are mated with the blood glucose reference data of cloud server, generates multiple dependency area sampling positional information, sampling depth information and user's skin texture model, blood glucose value generating reference model according to matching result;
OCT regulon, controlling activation bit for generating according to the dependency area sampling positional information obtained, sampling depth information and upper-arm circumference information relative to the OCT head angle of user's arm, controlling the anglec of rotation of activation bit adjustment OCT probe relative to user's arm by OCT head angle;
First display unit, gos deep into the depth information of Intelligent blood sugar instrument surveyed area for generating user's arm according to dependency area sampling positional information and brachium information and is shown to user;
Raw data acquisition unit, for after a default testing time puts, prompting user carries out blood sugar test; Extend into after in test chamber at the arm of user, after the horizontal displacement that user adjusts OCT probe falling head and keeper after the first Preset Time, generate the activation bit triggering OCT probe acquires function, according to activation bit, the skin optical initial data of this dependency area sampling position of control OCT probe acquires, and reading revises through user's skin texture model the skin optical data obtained to skin optical initial data;
Blood glucose value generation unit, for the blood glucose value according to revised this dependency area sampling position of skin optical data application blood glucose value generating reference model generation;
Repetitive, for according to the function of the arm mobile message of user successively repeated priming raw data acquisition unit, blood glucose value generation unit until the blood glucose value of all dependency area sampling positional informationes all gathers complete; Judge whether the blood glucose value of all dependency area sampling positional informationes all gathers complete in the second Preset Time, when the blood glucose value having dependency area sampling positional information does not gather, generate and show the prompting of the blood glucose value collection activity of the dependency area sampling positional information that user's Resurvey does not complete, and start the function of raw data acquisition unit, repeated priming raw data acquisition unit, blood glucose value generation unit, repetitive successively; When the blood glucose value of all dependency area sampling positional informationes gathers complete, start the function of the second display unit;
Second display unit, for the meansigma methods of all blood glucose values according to all blood glucose value information generating reference evaluation informations gathered, comparative information and once complete collection, store and show the meansigma methods of all blood glucose values of this reference evaluation information, comparative information and this complete collection.
CN201510306660.7A 2015-06-05 2015-06-05 Intelligent blood sugar tester, method of testing and system Active CN104856696B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510306660.7A CN104856696B (en) 2015-06-05 2015-06-05 Intelligent blood sugar tester, method of testing and system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510306660.7A CN104856696B (en) 2015-06-05 2015-06-05 Intelligent blood sugar tester, method of testing and system

Publications (2)

Publication Number Publication Date
CN104856696A true CN104856696A (en) 2015-08-26
CN104856696B CN104856696B (en) 2017-11-10

Family

ID=53903206

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510306660.7A Active CN104856696B (en) 2015-06-05 2015-06-05 Intelligent blood sugar tester, method of testing and system

Country Status (1)

Country Link
CN (1) CN104856696B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112120708A (en) * 2020-09-24 2020-12-25 常州市第一人民医院 Blood glucose monitoring intelligent device for developing and glucose-regulating 18F-FDG PET surviving cardiac muscle

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070232873A1 (en) * 2006-03-16 2007-10-04 The Board Of Regents Of The University Of Texas Syatem Noninvasive, accurate glucose monitoring with oct by using tissue warming and temperature control
WO2008076228A2 (en) * 2006-12-13 2008-06-26 Newton Photonics, Inc. Interferometric method and instrument for measurement and monitoring blood glucose
CN201519152U (en) * 2009-09-25 2010-07-07 深圳先进技术研究院 Noninvasive blood sugar detecting system
US20110082709A1 (en) * 2009-10-02 2011-04-07 Institute For Information Industry System and device and method for blood sugar level analysis and computer readable recording medium storing computer program performing the method
CN102043894A (en) * 2009-10-13 2011-05-04 北京大学 Physiological data monitoring system and method
CN203314969U (en) * 2013-06-05 2013-12-04 苏州光环科技有限公司 Noninvasive blood glucose collection and measuring device
CN103767691A (en) * 2014-02-17 2014-05-07 张雅儒 Real-time diagnosis system based on mobile terminal
CN104147663A (en) * 2014-09-01 2014-11-19 江苏昀锐生物科技有限公司 Insulin injection service system based on cloud technology
CN104323781A (en) * 2014-11-10 2015-02-04 上海翰临电子科技有限公司 Blood glucose analysis method and monitoring equipment

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070232873A1 (en) * 2006-03-16 2007-10-04 The Board Of Regents Of The University Of Texas Syatem Noninvasive, accurate glucose monitoring with oct by using tissue warming and temperature control
WO2008076228A2 (en) * 2006-12-13 2008-06-26 Newton Photonics, Inc. Interferometric method and instrument for measurement and monitoring blood glucose
CN201519152U (en) * 2009-09-25 2010-07-07 深圳先进技术研究院 Noninvasive blood sugar detecting system
US20110082709A1 (en) * 2009-10-02 2011-04-07 Institute For Information Industry System and device and method for blood sugar level analysis and computer readable recording medium storing computer program performing the method
CN102043894A (en) * 2009-10-13 2011-05-04 北京大学 Physiological data monitoring system and method
CN203314969U (en) * 2013-06-05 2013-12-04 苏州光环科技有限公司 Noninvasive blood glucose collection and measuring device
CN103767691A (en) * 2014-02-17 2014-05-07 张雅儒 Real-time diagnosis system based on mobile terminal
CN104147663A (en) * 2014-09-01 2014-11-19 江苏昀锐生物科技有限公司 Insulin injection service system based on cloud technology
CN104323781A (en) * 2014-11-10 2015-02-04 上海翰临电子科技有限公司 Blood glucose analysis method and monitoring equipment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112120708A (en) * 2020-09-24 2020-12-25 常州市第一人民医院 Blood glucose monitoring intelligent device for developing and glucose-regulating 18F-FDG PET surviving cardiac muscle

Also Published As

Publication number Publication date
CN104856696B (en) 2017-11-10

Similar Documents

Publication Publication Date Title
US10019554B2 (en) Glycemic risk determination based on variability of glucose
US10448928B2 (en) Method and device for detecting physiological index
RU2749187C2 (en) Computer-implemented method and portable apparatus for analysis of glucose control data indicating glucose level in bodily fluid
EP3925533B1 (en) Performance reports associated with continuous sensor data from multiple analysis time periods
KR101736976B1 (en) Apparatus and method for measuring biological signal
JP6651356B2 (en) System and method for processing analyte data and generating reports
JP5266221B2 (en) Method and apparatus for monitoring physiological parameters
ES2575660T3 (en) System, tools, devices and program for diabetic care
JP6173301B2 (en) Regularized network-based glucose predictor with adaptively selected kernel and regularization parameters
JP6426609B2 (en) System and method for assessing risk associated with glucose status
US20230346306A1 (en) Methods and systems to detect eating
CN111588384B (en) Method, device and equipment for obtaining blood glucose detection result
WO2005067633A2 (en) Method and apparatus for presentation of noninvasive glucose concentration information
EP2427102A2 (en) System and method for monitoring blood glucose levels non-invasively
KR102349961B1 (en) Health care apparatus and method of operating of the apparatus
Maritsch et al. Towards wearable-based hypoglycemia detection and warning in diabetes
US11998321B2 (en) System and a method for automatically managing continuous glucose monitoring measurements indicative of glucose level in a bodily fluid
JP2012045191A (en) Blood sugar level prediction device
US20150320327A1 (en) Hemodynamics measurement apparatus and hemodynamics measurement method
US20050137470A1 (en) Method and apparatus for low blood glucose level detection
US9538943B1 (en) Blood glucose monitor and method of use thereof
JP2008253727A (en) Monitor device, monitor system and monitoring method
CN104856696A (en) Intelligent blood glucose test instrument, method and system
EP2829225A1 (en) Method and device for non-invasive checking of the glucose level in the blood
Labat et al. Wearable Blood Pressure Monitoring System-Case Study of Multiplatform Applications for Medical Use

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20170718

Address after: 510640 Guangdong City, Tianhe District Province, No. five, road, public education building, unit 371-1, unit 2401

Applicant after: Guangdong Gaohang Intellectual Property Operation Co., Ltd.

Address before: 430000 Hubei Province, Wuhan city Hongshan District Qingling Avenue Baishazhou city garden three 501 building 4 unit 1101

Applicant before: Zhang Xiaoxiao

TA01 Transfer of patent application right

Effective date of registration: 20170905

Address after: Wuchuan City, Guangdong province 524500 yellow Pozhen Zhanjiang, Macun No. 125

Applicant after: Chen Silin

Address before: 510640 Guangdong City, Tianhe District Province, No. five, road, public education building, unit 371-1, unit 2401

Applicant before: Guangdong Gaohang Intellectual Property Operation Co., Ltd.

TA01 Transfer of patent application right
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Wang Chun

Inventor after: Li Yan

Inventor after: Yang Shaojie

Inventor after: Xie Wenchun

Inventor before: Zhang Xiaoxiao

TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20170908

Address after: Foshan City Hing Road Shunde District 528000 Guangdong city of Foshan province No. 1 room 315

Applicant after: GUANGDONG ZHONGKEKANGYI BIOTECHNOLOGY CO., LTD.

Address before: Wuchuan City, Guangdong province 524500 yellow Pozhen Zhanjiang, Macun No. 125

Applicant before: Chen Silin

GR01 Patent grant
GR01 Patent grant